Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Psychedelic Drugs

Psychedelic experiences share many features with those described by mystics and religious practitioners

by Eric W. Dolan
September 5, 2020
in Psychedelic Drugs
(Photo credit: agsandrew)

(Photo credit: agsandrew)

Share on TwitterShare on Facebook
Don't miss out! Follow PsyPost on Bluesky!

Scientists in Finland are taking a closer look the relationship between psychedelic substances and mystical experiences. In new research published in Journal of Psychoactive Drugs, researchers show that a Finnish version of a common assessment of subjective psychedelic effects can accurately capture individuals’ experiences.

“Studies with both clinical populations and healthy volunteers, as well as population-based research, suggest that some people experience positive changes in well-being and relationships after using psychedelics,” said study author Samuli Kangaslampi, a postdoctoral researcher at Tampere University.

“Undergoing mystical-type experiences under their influence may be one possible mechanism that could lead to such changes. However, research on psychedelic-induced mystical-type experiences has been limited to a few distinct cultural environments, and there was little to no previous research from Nordic contexts on psychedelics in general. This may be relevant in a complex phenomenon such as mystical-type experiences and their meaning and relevance.”

In a study of 288 psychedelic users who were fluent in Finnish, the researchers found that a Finnish translation of the 30-item revised Mystical Experience Questionnaire was a valid and reliable measure of mystical experiences. The revised Mystical Experience Questionnaire, also known as the MEQ30, was initially developed in English to assess the occurrence and character of discrete mystical experiences, such as the feeling that one has transcended time and space.

Kangaslampi and his colleagues found that those who scored high on the MEQ30 were more likely to also describe their psychedelic experience as mystical, spiritual, or religious, as well as more personally significant. “Correlations with the experience being fun, sad, or difficult were also significant, but weaker,” the researchers said.

“Even when taken for the first time, psychedelics may occasion powerful subjective experiences that share many features with those described by mystics, dedicated meditators, and religious practitioners. Researchers studying psychedelics are developing ways of assessing such experiences as well as their meaning and possible effects. Some research is beginning to demonstrate that undergoing a mystical-type experience may be linked to improved relationships with self, others, and the natural environment later on,” Kangaslampi told PsyPost.

Creating a scientifically-validated translation of the MEQ30 provides new opportunities for researchers to investigate the effects of psychedelic drugs.

“The goal of this study was mainly to validate a measure of mystical experiences and begin to elucidate whether psychedelic-induced mystical-type experiences, their features, and their relevance differ in different cultural contexts. As such, the sample this research is based is not intended to be representative of all people who take psychedelics for the first time, in Finland or in general. Moreover, participants were reporting on first times that in many cases took place years earlier,” Kangaslampi explained.

“As for the role and relevance of mystical-type experiences more generally, we face two major questions. First, the possible unique contribution of mystical-type experiences in promoting positive changes after psychedelic use when other putative psychological mechanisms of change are taken into account remains to be established.”

“Second, while powerful and profound experiences occur in many users of psychedelics, there is still debate about whether their relevant features are most appropriately described as mystical-type experiences, peak experiences, or emotional breakthroughs,” Kangaslampi said.

The study, “Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland“, was authored by Samuli Kangaslampi, Aino Hausen, and Tarina Rauteenmaa.

TweetSendScanShareSendPin5ShareShareShareShareShare

RELATED

Little-known psychedelic found to have a fascinating effect on cognitive flexibility after just a single dose
Psychedelic Drugs

Fascinating new advances in psychedelic science reveal how they may heal the mind

July 9, 2025

A series of recent studies has begun to map the specific neural, cognitive, and emotional processes that psychedelics influence—often in ways that challenge long-held assumptions

Read moreDetails
Use of mescaline may facilitate unintended improvements in several psychiatric conditions, study suggests
Ayahuasca

Many ayahuasca users report challenging experiences—yet some are linked to better mental health

July 4, 2025

Are challenging ayahuasca experiences always harmful? Not necessarily, finds a new global survey. While some effects predict poorer mental health, others like visual distortions are linked to positive outcomes, highlighting the crucial role of context and individual vulnerability.

Read moreDetails
Psychedelic compound blurs boundary between self and others in the brain, study finds
Ayahuasca

Psychedelic compound blurs boundary between self and others in the brain, study finds

July 2, 2025

A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting self-referential processing while preserving recognition of familiar faces, suggesting a neural basis for psychedelic-induced ego dissolution.

Read moreDetails
Researchers identify neural mechanism behind memory prioritization
MDMA

New study reveals how MDMA rewires serotonin and oxytocin systems in the brain

June 30, 2025

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems. The drug suppressed serotonin signaling, boosted oxytocin receptor expression, and modulated brain signaling proteins involved in emotional regulation.

Read moreDetails
Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds
Neuroimaging

Regular psychedelic users exhibit different brain responses to self-related thoughts, study finds

June 28, 2025

A new study suggests that regular users of psychedelics may process self-related thoughts differently at both psychological and brain levels, revealing altered patterns of brain activity during self-reflection compared to non-users who intend to try psychedelics.

Read moreDetails
Psychedelic use linked to increased risk of unusual visual experiences
Ayahuasca

Study links moderate awe in psychedelic ayahuasca journeys to better well-being

June 21, 2025

A new study published in the Journal of Psychoactive Drugs suggests that while awe can be transformative during ayahuasca retreats, there’s a limit. Experiences marked by excessive vastness were linked to lower well-being, challenging assumptions about awe’s universal benefits.

Read moreDetails
About 8% of psychedelic users report inappropriate sexual contact by guides
Psychedelic Drugs

Study links psychedelic use in illegal settings to increased psychotic and manic symptoms

June 18, 2025

New research suggests that naturalistic psychedelic use may worsen psychotic and manic symptoms when used in illegal settings. People with schizophrenia or bipolar I disorder appeared especially vulnerable to these effects, highlighting the importance of context and psychiatric background.

Read moreDetails
Some dark personality traits may help buffer against depression, new psychology research suggests
Mental Health

Psilocybin-assisted therapy linked to reduced depression in people with bipolar disorder, small study finds

June 17, 2025

A pilot study involving psilocybin-assisted therapy found possible antidepressant effects for people with bipolar II disorder. The treatment appeared well-tolerated, with no signs of mania or psychosis, offering cautious optimism for future bipolar depression research.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Frequent egg consumption linked to lower risk of Alzheimer’s dementia, study finds

Psychopathic personality and weak impulse control pair up to predict teen property crime

Low sexual activity, body shape, and mood may combine in ways that shorten lives, new study suggests

Highly irritable teens are more likely to bully others, but anxiety mitigates this tendency

Neuroscientists identify brain pathway that prioritizes safety over other needs

Liberals and conservatives live differently — but people think the divide is even bigger than it is

Neuroscientists shed new light on how heroin disrupts prefrontal brain function

New research identifies four distinct health pathways linked to Alzheimer’s disease

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy